Product How it works Pricing Blog FAQ About Contact
Albemarle

Albemarle (NYSE: ALB) revenue

Albemarle reported revenue of $5,143m for fiscal 2025, 4.4% less than in fiscal 2024 ($5,378m). Since fiscal 2016 its revenue has grown by 92.1%, an average growth of 7.5% a year.

Revenue, in millions of US dollars2,67720163,07220173,37520183,58920193,12920203,32820217,32020229,61720235,37820245,1432025

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$5,143m−4.4%−$367.1m−7.1%
2024$5,378m−44.1%−$1,777m−33.0%
2023$9,617m+31.4%$251.9m2.6%
2022$7,320m+120.0%$2,470m33.7%
2021$3,328m+6.4%$798.4m24.0%
2020$3,129m−12.8%$505.8m16.2%
2019$3,589m+6.4%$666.1m18.6%
2018$3,375m+9.9%$911.5m27.0%
2017$3,072m+14.7%$571.7m18.6%
2016$2,677m—$601.0m22.4%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the revenue of Albemarle

How much revenue did Albemarle make in fiscal 2025?
Albemarle reported revenue of $5,143m for fiscal 2025, compared with $5,378m in fiscal 2024.
How much has the revenue of Albemarle grown?
Between fiscal 2016 and fiscal 2025 it went from $2,677m to $5,143m: 92.1% more, an average growth of 7.5% a year.
What was the best year for revenue at Albemarle?
Of its last 10 fiscal years, fiscal 2023, with $9,617m.
Where do the figures for Albemarle come from?
From the annual report (Form 10-K) that Albemarle files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Albemarle files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Albemarle: the Albemarle page · annual accounts · net income · dividends paid · insider transactions.

Dividend per share of Albemarle by fiscal year, with the filing behind every figure: Albemarle dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.